Sign in

CIK 0001699031 · Non-accelerated filer<br>Emerging growth company

GRAIL, Inc.

Sign in to watch
Ticker
GRAL
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
863673636
Phone
(833) 694-2553
Business address
250 S. MATHILDA AVENUE, SUITE 100, SUNNYVALE, CA, 94086
Former names
GRAIL, LLC
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. SCHEDULE 13G Stake Statement of Beneficial Ownership
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. 4 Grant or award Director acquired 276 shares (grant or award)
  8. 4 Grant or award Director acquired 427 shares (grant or award)
  9. 4 Grant or award Director acquired 268 shares (grant or award)
  10. 4 Grant or award Director acquired 5,491 shares (grant or award)
  11. 4 Grant or award Director acquired 5,491 shares (grant or award)
  12. 4 Grant or award Director acquired 5,491 shares (grant or award)
  13. 4 Grant or award Director acquired 5,491 shares (grant or award)
  14. 8-K Event Shareholder vote results
  15. 4 Open-market sale Chief Growth Officer sold 1,491 shares at $61.08 ($91,070)
  16. 4 Grant or award Chief Executive Officer acquired 31,055 shares (grant or award)
  17. 144 Insider Sale of Securities
  18. 3 Insider Initial Statement of Ownership
  19. 8-K Event Executive or director change · Other events
  20. SCHEDULE 13G/A Stake Statement of Beneficial Ownership

Page 2 of 14 · 267 filings